Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer.
Park J, Park BB, Kim JY, Lee SH, Lee SI, Kim HY, Kim JH, Park SH, Lee KE, Park JO, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Park K.
Park J, et al. Among authors: lee sh, lee si, lee mh, lee ke.
Clin Cancer Res. 2004 Jul 1;10(13):4383-8. doi: 10.1158/1078-0432.CCR-04-0189.
Clin Cancer Res. 2004.
PMID: 15240526